Sartorius Stedim Biotech S.A. (SRTOY)
OTCMKTS · Delayed Price · Currency is USD
21.14
-1.75 (-7.67%)
At close: Feb 11, 2026
Sartorius Stedim Biotech Revenue
Sartorius Stedim Biotech had revenue of 705.70M EUR in the quarter ending September 30, 2025, with 7.67% growth. This brings the company's revenue in the last twelve months to 2.95B, up 7.72% year-over-year. In the year 2024, Sartorius Stedim Biotech had annual revenue of 2.78B with 0.16% growth.
Revenue (ttm)
2.95B EUR
Revenue Growth
+7.72%
P/S Ratio
5.80
Revenue / Employee
290.76K EUR
Employees
10,134
Market Cap
20.04B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.78B | 4.50M | 0.16% |
| Dec 31, 2023 | 2.78B | -717.20M | -20.53% |
| Dec 31, 2022 | 3.49B | 605.70M | 20.98% |
| Dec 31, 2021 | 2.89B | 976.92M | 51.15% |
| Dec 31, 2020 | 1.91B | 469.51M | 32.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Meihua International Medical Technologies | 89.55M |
| Encision | 6.30M |
| Lancer Orthodontics | 6.19M |
| Reflect Scientific | 1.72M |
| Ozop Energy Solutions | 323.50K |
| Standard Dental Labs | 306.82K |
| Hear AtLast Holdings | 93.20K |
| Cardiac Biotech Solutions | 50.37K |
Sartorius Stedim Biotech News
- 8 days ago - Sartorius Stedim Biotech SA (SDMHF) Q4 2025 Earnings Call Highlights: Strong Profit Growth and ... - GuruFocus
- 8 days ago - Sartorius Stedim Biotech S.A. (SRTOY) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Preliminary Q4 2025 Sartorius AG and Sartorius Stedim Biotech SA Earnings Call Transcript - GuruFocus
- 8 days ago - Sartorius Stedim Biotech S.A. 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 9 days ago - Sartorius Stedim Biotech FY25 Results Climb; Sees Growth In FY26, Beyond - Nasdaq
- 9 days ago - Sartorius Stedim Biotech S.A. Non-GAAP EPS of €4.40, revenue of €2.97B; initates FY26 outlook - Seeking Alpha
- 4 months ago - Q3 2025 Sartorius AG and Sartorius Stedim Biotech SA Earnings Call Transcript - GuruFocus
- 4 months ago - Sartorius Stedim (SDMHF) Reports Strong Q3 Earnings and Updates Guidance - GuruFocus